(ANAB) – Analyst Comments
-
BTIG Starts AnaptysBio (ANAB) at Buy, 'Novel Therapies in Large Markets Make a Compelling Case for Upside'
-
Piper Sandler Starts AnaptysBio (ANAB) at Overweight
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ANAB Stock Lookup